Published in BMC Musculoskelet Disord on January 17, 2011
Lessons from community mental health to drive implementation in health care systems for people with long-term conditions. Int J Environ Res Public Health (2014) 0.82
Patients' perspectives on the medical primary-secondary care interface: systematic review and synthesis of qualitative research. BMJ Open (2015) 0.79
The relationship between GPs and hospital consultants and the implications for patient care: a qualitative study. BMC Fam Pract (2016) 0.78
Designing an intervention for women with systemic lupus erythematosus from medically underserved areas to improve care: a qualitative study. Lupus (2012) 0.78
Unexpected deaths in cardiology outpatients - what can we learn from case review? JRSM Open (2016) 0.75
Three approaches to qualitative content analysis. Qual Health Res (2005) 56.35
Qualitative interviews in medical research. BMJ (1995) 11.14
Use of multiperspective qualitative interviews to understand patients' and carers' beliefs, experiences, and needs. BMJ (2009) 1.72
Discourse analysis. BMJ (2008) 1.68
Beneficial effects of a 3-week course of intramuscular glucocorticoid injections in patients with very early inflammatory polyarthritis: results of the STIVEA trial. Ann Rheum Dis (2009) 1.63
Early inflammatory polyarthritis: results from the Norfolk Arthritis Register with a review of the literature. II. Outcome at three years. Rheumatology (Oxford) (2000) 1.54
BSR guidelines on standards of care for persons with rheumatoid arthritis. Rheumatology (Oxford) (2005) 1.35
Palliative care in the community for cancer and end-stage cardiorespiratory disease: the views of patients, lay-carers and health care professionals. Palliat Med (2005) 1.35
Racial disparities in treatment preferences for rheumatoid arthritis. Med Care (2009) 1.21
Quality of rheumatoid arthritis care: the patient's perspective. Int J Qual Health Care (2004) 1.09
Two-year follow-up of a randomized controlled trial of a clinical nurse specialist intervention, inpatient, and day patient team care in rheumatoid arthritis. J Adv Nurs (2003) 1.08
A comparison of the views of rheumatologists, general practitioners and patients on the treatment of osteoarthritis. Rheumatology (Oxford) (2002) 1.03
Patients' views on the quality of health care for rheumatoid arthritis. Rheumatology (Oxford) (2006) 1.01
The influence of ethnicity on the extent of, and reasons underlying, delay in general practitioner consultation in patients with RA. Rheumatology (Oxford) (2010) 0.99
What factors account for referral delays for patients with suspected rheumatoid arthritis? Arthritis Rheum (2006) 0.95
Time to treatment in rheumatoid arthritis: factors associated with time to treatment initiation and urgent triage assessment of general practitioner referrals. J Clin Rheumatol (2010) 0.93
Optimal care for rheumatoid arthritis: a focus group study. Clin Rheumatol (2010) 0.92
Differential shared care for diabetes: does it provide the optimal partition between primary and specialist care? Diabet Med (2001) 0.80
It's not that bad: the views of consumers and carers about routine outcome measurement in mental health. Aust Health Rev (2009) 0.78
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis (2013) 10.92
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis (2010) 10.03
A randomized placebo-controlled trial of methotrexate in psoriatic arthritis. Rheumatology (Oxford) (2012) 3.56
The diagnosis and prognosis of early arthritis: rationale for new prognostic criteria. Arthritis Rheum (2002) 2.15
Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis. J Rheumatol (2005) 1.81
Illness beliefs predict disability in rheumatoid arthritis. J Psychosom Res (2009) 1.62
Association of R602W in a protein tyrosine phosphatase gene with a high risk of rheumatoid arthritis in a British population: evidence for an early onset/disease severity effect. Arthritis Rheum (2005) 1.59
Remission in early rheumatoid arthritis. J Rheumatol (2010) 1.55
Economic aspects of treatment options in rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis (2010) 1.54
Impact of locoregional therapy and alpha-fetoprotein on outcomes in transplantation for liver cancer: a UNOS Region 6 pooled analysis. Clin Transplant (2012) 1.44
Cost-effectiveness of combination nonbiologic disease-modifying antirheumatic drug strategies in patients with early rheumatoid arthritis. J Rheumatol (2011) 1.40
Prescribed exercise in people with fibromyalgia: parallel group randomised controlled trial. BMJ (2002) 1.37
Huntingtin associates with acidic phospholipids at the plasma membrane. J Biol Chem (2005) 1.22
Fibromyalgic rheumatoid arthritis and disease assessment. Rheumatology (Oxford) (2010) 1.21
Co-morbidities in established rheumatoid arthritis. Best Pract Res Clin Rheumatol (2011) 1.19
The relationship between social deprivation, disease outcome measures, and response to treatment in patients with stable, long-standing rheumatoid arthritis. J Rheumatol (2005) 1.16
African American living-kidney donors should be screened for APOL1 risk alleles. Transplantation (2011) 1.15
Donation after cardiac death: the University of Wisconsin experience. Ann Transplant (2004) 1.14
A systematic comparison of combination DMARD therapy and tumour necrosis inhibitor therapy with methotrexate in patients with early rheumatoid arthritis. Rheumatology (Oxford) (2009) 1.13
Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma. Cancer Res (2002) 1.10
Setting goals, solving problems, and seeking social support: developing adolescents' abilities through a life skills program. Adolescence (2007) 1.07
Cancer diagnosis in people with severe mental illness: practical and ethical issues. Lancet Oncol (2010) 1.04
The impact of disease activity, pain, disability and treatments on fatigue in established rheumatoid arthritis. Clin Rheumatol (2011) 1.03
Uptake, efficacy, and systemic distribution of naked, inhaled short interfering RNA (siRNA) and locked nucleic acid (LNA) antisense. Mol Ther (2011) 1.03
CpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastoma. Cancer Res (2003) 1.03
Quality of life and the outcome of established rheumatoid arthritis. Best Pract Res Clin Rheumatol (2011) 1.00
Development and validation of a patient-based disease activity score in rheumatoid arthritis that can be used in clinical trials and routine practice. Arthritis Rheum (2008) 0.93
Is shared care with annual hospital review better value for money than predominantly hospital-based care in patients with established stable rheumatoid arthritis? Ann Rheum Dis (2006) 0.93
Waiting time predicts survival after liver transplantation for hepatocellular carcinoma: a cohort study using the United Network for Organ Sharing registry. Liver Transpl (2014) 0.91
Patients' views about treatment with combination therapy for rheumatoid arthritis: a comparative qualitative study. BMC Musculoskelet Disord (2012) 0.91
Disease-modifying antirheumatic drugs other than methotrexate in rheumatoid arthritis and seronegative arthritis. Curr Opin Rheumatol (2008) 0.90
Remission in early rheumatoid arthritis: predicting treatment response. J Rheumatol (2012) 0.89
The patient's journey: rheumatoid arthritis. BMJ (2005) 0.87
Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment: Six-month, double-blind, randomized, placebo-controlled trial. Arthritis Rheum (2007) 0.87
Can we discontinue synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis? Clin Exp Rheumatol (2013) 0.86
Current limitations in the management of cardiovascular risk in rheumatoid arthritis. Clin Exp Rheumatol (2012) 0.86
Pain thresholds in rheumatoid arthritis: the effect of tender point counts and disease duration. J Rheumatol (2011) 0.86
Current perspectives on tocilizumab for the treatment of rheumatoid arthritis: a review. Patient Prefer Adherence (2013) 0.86
New tumour necrosis factor inhibitors for rheumatoid arthritis: are there benefits from extending choice? Ann Rheum Dis (2009) 0.84
Non-steroidal anti-inflammatory drugs and cardiac failure: meta-analyses of observational studies and randomised controlled trials. Eur J Heart Fail (2008) 0.84
Implications of long-term conditions for both mental and physical health: comparison of rheumatoid arthritis and schizophrenia. Qual Life Res (2009) 0.84
Crystallization and preliminary X-ray analysis of recombinant human acid beta-glucocerebrosidase, a treatment for Gaucher's disease. Acta Crystallogr D Biol Crystallogr (2003) 0.84
Drug therapy of inflammatory arthritis. Clin Med (2012) 0.83
Comparative quality of life in patients with depression and rheumatoid arthritis. Int Rev Psychiatry (2011) 0.82
ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: secondary analysis of a randomized controlled trial. Arthritis Res Ther (2014) 0.82
Survivin expression in juvenile-onset recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol (2002) 0.82
Are patients meeting the updated physical activity guidelines? Physical activity participation, recommendation, and preferences among inner-city adults with rheumatic diseases. J Clin Rheumatol (2012) 0.81
Clinical effectiveness of biologics in clinical practice. Arthritis Res Ther (2010) 0.81
Hepatic and cardiac iron overload among patients with end-stage liver disease referred for liver transplantation. Clin Transplant (2010) 0.80
The development and psychometric properties of the Humanitarian Emergency Settings Perceived Needs (HESPER) Scale. Am J Public Health (2012) 0.80
Outcomes associated with early rheumatoid arthritis. Expert Rev Pharmacoecon Outcomes Res (2006) 0.80
Nonvolitional assessment of muscle endurance in idiopathic inflammatory myopathies: there is no relationship between patient-reported fatigue and muscle fatigability. Muscle Nerve (2014) 0.79
Treating inflammatory arthritis early. BMJ (2010) 0.79
Treatment of rheumatoid arthritis is good medicine. BMJ (2011) 0.79
Polymyositis. BMJ (2012) 0.77
Hydroxychloroquine effectiveness in reducing symptoms of hand osteoarthritis (HERO): study protocol for a randomized controlled trial. Trials (2013) 0.77
Spleen tyrosine kinase inhibitors for rheumatoid arthritis: where are we now? Drugs (2014) 0.77
Clinical and radiological features of rheumatoid arthritis in British black Africans. Clin Rheumatol (2007) 0.77
Teaching in partnership: linking a medical school and a community trust. Br J Community Nurs (2002) 0.77
Education, self-management, and upper extremity exercise training in people with rheumatoid arthritis: a randomized controlled trial. Arthritis Care Res (Hoboken) (2014) 0.77
Mycophenolate mofetil in the treatment of adults with advanced rheumatoid arthritis: three 24-week, randomized, double-blind, placebo- or ciclosporin-controlled trials. Clin Drug Investig (2010) 0.77
Interstitial lung disease and disease modifying anti-rheumatic drugs. Lancet (2004) 0.76
Treating early rheumatoid arthritis intensively: current UK practice does not reflect guidelines. Clin Rheumatol (2010) 0.76
Rapid isolation of DNA from chocolate and date palm tree crops. J Agric Food Chem (2004) 0.76
Use of imaging to assess patients with muscle disease. Curr Opin Rheumatol (2004) 0.75
Adding new perspectives to the kaleidoscope of remission criteria in rheumatoid arthritis. J Rheumatol (2013) 0.75
Translating research into practice: acetaminophen in osteoarthritis revisited. J Rheumatol (2004) 0.75
Comment on: A randomized placebo-controlled trial of methotrexate in psoriatic arthritis: reply. Rheumatology (Oxford) (2013) 0.75
So you want to be ... a rheumatologist. Br J Hosp Med (Lond) (2010) 0.75
Crystallization and preliminary X-ray analysis of Der f 2, a potent allergen derived from the house dust mite (Dermatophagoides farinae). Acta Crystallogr D Biol Crystallogr (2003) 0.75
Payers' views on treating-to-target in rheumatoid arthritis: an English perspective. Clin Exp Rheumatol (2012) 0.75
Sexual education for psychiatric residents. Acad Psychiatry (2010) 0.75
Rheumatoid arthritis: clinical utility of the RAID (RA impact of disease) score. Nat Rev Rheumatol (2011) 0.75
Preface. Established rheumatoid arthritis. Best Pract Res Clin Rheumatol (2007) 0.75
So you want to be... a rheumatologist. Br J Hosp Med (Lond) (2007) 0.75